河北中医2024,Vol.46Issue(1) :56-60.DOI:10.3969/j.issn.1002-2619.2024.01.013

丹栀逍遥散加减方对精神分裂症患者高催乳素血症的影响研究

Effect of Modified Danzhi Xiaoyao Powder on hyperprolactinemia in schizophrenia patients

许桦 邢梦娟 孙扬 潘晓鸥 陆颖 吴海苏 朱丽萍 何永光
河北中医2024,Vol.46Issue(1) :56-60.DOI:10.3969/j.issn.1002-2619.2024.01.013

丹栀逍遥散加减方对精神分裂症患者高催乳素血症的影响研究

Effect of Modified Danzhi Xiaoyao Powder on hyperprolactinemia in schizophrenia patients

许桦 1邢梦娟 1孙扬 2潘晓鸥 2陆颖 1吴海苏 2朱丽萍 1何永光2
扫码查看

作者信息

  • 1. 上海交通大学医学院附属精神卫生中心中西医结合科,上海 201108;上海市中医神志病研究所,上海 201108
  • 2. 上海交通大学医学院附属精神卫生中心精神科,上海 201108
  • 折叠

摘要

目的 观察丹栀逍遥散加减方对精神分裂症患者高催乳素水平的影响.方法 将118 例精神分裂症并发有高催乳血症患者按照随机数字表法分为2 组,2 组均常规给予抗精神分裂症药物治疗,治疗组56 例予丹栀逍遥散加减方治疗,对照组62 例予安慰剂治疗.2 组均治疗12 周后.比较2 组治疗前及治疗 4、12 周血清催乳素、精神症状[采用阳性和阴性症状量表(PANSS)评分进行评价]及生活质量[采用精神分裂症患者生活质量量表(SQLS)进行评价,包括心理社会、动机/精力、症状/副反应 3 个方面]变化情况,统计分析治疗组治疗 12 周后血清催乳素水平与PANSS评分、SQLS评分之间的相关性.结果 与本组治疗前比较,治疗组治疗4、12 周血清催乳素水平均降低(P<0.05),且治疗组治疗4、12 周血清催乳素水平均低于对照组同期(P<0.05),但对照组治疗4、12 周血清催乳素水平与治疗前比较差异均无统计学意义(P>0.05).2 组治疗 4、12 周 PANSS评分与本组治疗前比较及组间比较差异均无统计学意义(P>0.05).与本组治疗前比较,治疗组治疗 4、12 周 SQLS 心理社会、动机/精力、症状/副反应评分及总分均降低(P<0.05),且治疗组治疗4、12 周SQLS心理社会、动机/精力、症状/副反应评分及总分均低于对照组同期(P<0.05),但对照组治疗4、12 周SQLS心理社会、动机/精力、症状/副反应评分及总分与治疗前比较差异均无统计学意义(P>0.05).经Pearson相关性分析显示,治疗组治疗 12 周血清催乳素水平与 SQSL 症状/副反应评分及总分存在正相关性(r = 0.259,P =0.005;r =0.263,P =0.004).结论 丹栀逍遥散加减方治疗精神分裂症患者高催乳素血症临床疗效确切,可有效降低患者血清催乳素水平,提高患者生活质量,是一种颇具治疗效应的临床辅助治疗手段.

Abstract

Objective To evaluate the effect of modified Danzhi Xiaoyao Powder on hyperprolactinemia in schizophrenia patients.Methods Totally 118 patients with schizophrenia were randomly assigned into a control group(n =62)and a treat-ment group(n =56).All patients were managed by antipsychotics,and the treatment group was treated with modified Danzhi Xi-aoyao Powder,while the control group was treated with placebo,the treatment was performed for 12 weeks for statistical efficacy.Before treatment and after 4 and 12 weeks of treatment,the positive and negative symptom scale(PANSS)scores were performed to evaluate serum prolactin and psychiatric symptoms.The Schizophrenia Quality of Life Scale(SQLS)involving psychosocial,motivation/energy,symptoms/side-effects three subscales was conducted to assess the quality of life.After 12 weeks of treat-ment,the correlation between serum prolactin level and PANSS score and SQLS score in the treatment group was statistically ana-lyzed.Results After treatment,the levels of 4-week and 12-week serum prolactin in the treatment group were significantly de-creased(P<0.05),and which were significantly lower in the treatment group than the control group(P<0.05),but there was no significant difference in serum prolactin between the levels of 4-week and 12-week and that before treatment in the control group(P>0.05).There was no significant difference in PANSS score between the levels of 4-week and 12-week and that be-fore treatment in the both groups(P>0.05).Compared with before treatment,the each dimension scores and total score of 4-week and 12-week SQLS in the treatment group were significantly decreased(P<0.05),and the scores in the treatment group were significantly lower than those in the control group(P<0.05).However,there was no significant difference in the each di-mension scores and total score of 4-week and 12-week SQLS in the control group compared with those before treatment(P>0.05).Pearson correlation analysis showed that there was a positive correlation between 12-week serum prolactin level and SQSL(symptoms/side-effects)score in the treatment group(r =0.259,P =0.005;r =0.263,P =0.004).Conclusion For schizophrenia patients with hyperprolactinemia,modified Danzhi Xiaoyao Powder has a definite clinical efficacy,which can effectively reduce the serum prolactin level and improve the quality of life.It is considered to be a clinical adjuvant therapy with therapeutic effect.

关键词

精神分裂症/催乳素/中药疗法/丹栀逍遥散

Key words

Schizophrenia/Hyperprolactinemia/Chinese medicine therapy/Danzhi Xiaoyao Powder

引用本文复制引用

基金项目

上海市科学技术委员会科研计划项目(17401932600)

上海市科学技术委员会科研计划项目(16401934700)

上海市科学技术委员会科研计划项目(10DZ1973300)

上海市卫生健康委员会中医重点专科培育项目(AB83180002019021)

出版年

2024
河北中医
河北省医学情报研究所,河北省中医药学会

河北中医

CSTPCD
影响因子:0.951
ISSN:1002-2619
参考文献量15
段落导航相关论文